Interferon β for secondary progressive multiple sclerosis: a systematic review

Loredana La Mantia; Laura Vacchi; Marco Rovaris; Carlo Di Pietrantonj; George Ebers; Sten Fredrikson; Graziella Filippini

doi:10.1136/jnnp-2012-303291

Article info

Multiple sclerosis

Review

Interferon β for secondary progressive multiple sclerosis: a systematic review

Authors

Loredana La Mantia Neurorehabilitation Unit, Multiple Sclerosis Centre, IRCCS S Maria Nascente Fondazione Don Gnocchi, Milano, Italy PubMed articles Google scholar articles
Laura Vacchi Neuroepidemiology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy PubMed articles Google scholar articles
Marco Rovaris Neurorehabilitation Unit, Multiple Sclerosis Centre, IRCCS S Maria Nascente Fondazione Don Gnocchi, Milano, Italy PubMed articles Google scholar articles
Carlo Di Pietrantonj Regional Reference Centre for Epidemiology, Cochrane Vaccines Field, Local Health Unit, Alessandria, Italy PubMed articles Google scholar articles
George Ebers Clinical Neurology, University of Oxford, Oxford, UK PubMed articles Google scholar articles
Sten Fredrikson Division of Neurology R54, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden PubMed articles Google scholar articles
Graziella Filippini Neuroepidemiology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy PubMed articles Google scholar articles

Correspondence to Dr L La Mantia, Multiple Sclerosis Centre, Neurorehabilitation Unit, IRCCS Santa Maria Nascente Fondazione Don Gnocchi, Via Capecelatro 66, I-20148 Milano, Italy; lamantialore{at}gmail.com

View Full Text

Citation

Mantia LL, Vacchi L, Rovaris M, et al

Interferon β for secondary progressive multiple sclerosis: a systematic review

Journal of Neurology, Neurosurgery & Psychiatry 2013;84:420-426.

Publication history

Received May 26, 2012
Revised August 7, 2012
Accepted August 10, 2012
First published September 5, 2012.

Online issue publication

April 13, 2016

Article Versions

Previous version (13 April 2016).
You are viewing the most recent version of this article.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Article Versions

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password